148 results
Page 2 of 8
424B5
wrs9g1wazjj 843vf
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
smcpjkukwpj8
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
q41c rtjg
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.2
k4eebik2djblew003
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
EX-4.4
c2vqw3m 4p
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-23.1
ww3kbzfns
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.3
9ki9ra3rr6tm az
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
rmhkxdudwjrz qm
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-23.2
tsu fsgo1az6rcb
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-23.3
y7a5s4 tw9qx
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
8qfby4tbiq2 wd
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
S-8
n59ngxg5893835
2 Feb 24
Registration of securities for employees
4:04pm
S-8
EX-23.3
5b16 0re306wv
2 Feb 24
Registration of securities for employees
4:04pm
S-8
EX-23.1
lggfmb4rxr6 ba
2 Feb 24
Registration of securities for employees
4:04pm
S-8
EX-23.2
7hepree 5vtekjnpdrf8
2 Feb 24
Registration of securities for employees
4:04pm
8-K
EX-10.2
ol5ni0r6ovs7xxkc
29 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K/A
EX-23.1
gex27l owti0fmcx73
22 Nov 23
Report of Independent Auditors
4:02pm
8-K/A
3fzfkustkdwm7
22 Nov 23
Report of Independent Auditors
4:02pm
8-K/A
EX-99.1
p8x lkedd
22 Nov 23
Report of Independent Auditors
4:02pm